Elite Pain Consultants, PLLC

Elite Pain Consultants, PLLC was paid $1.55M by Medicaid between Jun 2018 and Oct 2023, across 69 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 59% of everything it billed.

33Billing provider infoELITE PAIN CONSULTANTS, PLLC
CLEVELAND, TN 37311

33aNPI1497267173assigned 11/02/2017

33bProvider typeInterventional Pain Medicine Physician

28Total paid$1.55M

24GClaims87,664

24DCodes billed69

24AFirst – last monthJun 2018 – Oct 2023

Compared with peers

Next to other Interventional Pain Medicine Physician providers in Tennessee

Rank by total paid#2 of 8

Median peer was paid$121K

This provider vs. median13×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	2,519	$57K
2019	17,162	$481K
2020	15,672	$399K
2021	24,338	$318K
2022	25,803	$267K
2023	2,170	$24K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	59%	39,382	33,686	$916K
J3300	Injection, triamcinolone acetonide, preservative free, 1 mg	12%	1,879	761	$190K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	5.4%	1,647	1,453	$83K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	3.8%	4,262	3,836	$59K
64493		3.8%	1,006	701	$58K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.0%	9,650	8,158	$31K
64494		1.8%	995	696	$28K
64635		1.7%	207	140	$26K
80305		1.6%	3,897	3,427	$25K
96132		1.4%	2,359	1,691	$21K
96130		1.1%	2,496	1,749	$17K
27096		1.1%	106	79	$16K

57 more codes

81025		<1%	3,359	$15K
64636		<1%	290	$12K
62323		<1%	80	$6K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	1,373	$5K
96138		<1%	2,530	$4K
72114		<1%	220	$4K
G3002	Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.)	<1%	369	$4K
20611		<1%	116	$3K
G0396	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes	<1%	2,423	$3K
64450		<1%	51	$3K
20553		<1%	83	$2K
64495		<1%	184	$1K
82962		<1%	988	$1K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	451	$1K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	202	$1K
99203	Doctor's office visit, new patient (routine)	<1%	30	$1K
G0444	Annual depression screening, 5 to 15 minutes	<1%	718	$939.74
76942		<1%	70	$887.81
83970		<1%	131	$452.52
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	45	$399.02
99421		<1%	64	$363.75
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	131	$324.67
82670		<1%	131	$305.85
72170		<1%	35	$301.90
84403		<1%	131	$282.94
72100		<1%	33	$282.29
73560		<1%	42	$280.04
82627		<1%	131	$243.73
84144		<1%	129	$219.34
84146		<1%	131	$212.58
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	650	$208.64
83001		<1%	131	$203.89
83002		<1%	132	$203.12
84481		<1%	131	$185.86
83003		<1%	131	$182.96
82533		<1%	131	$178.78
83735		<1%	245	$172.43
84443	Thyroid stimulating hormone (TSH)	<1%	130	$169.20
82607		<1%	131	$165.18
82746		<1%	131	$161.26
99406		<1%	35	$153.89
82977		<1%	242	$118.28
83615		<1%	246	$104.87
86431		<1%	244	$98.42
84439		<1%	131	$90.73
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	53	$89.55
84550		<1%	244	$78.26
80069		<1%	244	$71.86
36415	Collection of venous blood by venipuncture	<1%	262	$65.92
86140		<1%	131	$56.74
82728		<1%	241	$45.08
80053	Comprehensive metabolic panel	<1%	97	$39.52
83550		<1%	242	$28.98
83540		<1%	245	$21.39
80076		<1%	245	$6.22
84436		<1%	131	$6.18
84100		<1%	131	$3.94

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialELLEDGE, CASSY (REVENUE DIRECTOR)